0.69

0.10% 0.0007

After Hours: 2.58 1.89 +273.91%

Pharmacyte Biotech Inc (PMCB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Pharmacyte Biotech Inc stock is traded at $0.69, with a volume of 72,906. It is up +0.10% in the last 24 hours and down -2.10% over the past month. PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Previous Close:

$0.6893

Open:

$0.7065

24h Volume:

72,906

Relative Volume:

0.32

Market Cap:

$7.41M

Revenue:

Net Income/Loss:

$-3.28M

P/E Ratio:

-0.6631

EPS:

-1.0406

Net Cash Flow:

$-4.80M

1W Performance:

-11.56%

1M Performance:

-2.10%

6M Performance:

-31.68%

1Y Performance:

-46.92%

1-Day Range:

$0.6789

$0.749

1-Week Range:

$0.66

$0.819

52-Week Range:

$0.63

$1.51

Pharmacyte Biotech Inc Stock (PMCB) Company Profile

Name

Pharmacyte Biotech Inc

Sector

Healthcare (1118)

Industry

Biotechnology (624)

Phone

(917) 595.2850

Address

3960 HOWARD HUGHES PARKWAY, LAS VEGAS

Employee

Twitter

Next Earnings Date

2026-03-16

Latest SEC Filings

PMCB's Discussions on Twitter

Compare PMCB vs MOBBW, GOODO, PSNYW, SHMD, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PMCB	2.24	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	1.90	2.52B	0	0	0	0.00
GOODO Gladstone Commercial Corporation	19.70	372.90M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	3.94	364.47M	2.07B	-1.42B	-1.37B	-0.6765
SHMD Schmid Group N V	5.35	297.48M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	43.81	0	0	0	0	0.00

Pharmacyte Biotech Inc Stock (PMCB) Latest News

Apr 02, 2026

Director Weinstein receives 119,170 stock options at PharmaCyte Biotech (PMCB) - Stock Titan

Apr 02, 2026

Director at PharmaCyte Biotech (PMCB) gets 119,170 options - Stock Titan

Apr 02, 2026

PharmaCyte Biotech (PMCB) director awarded 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

PharmaCyte Biotech (PMCB) director receives 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

PharmaCyte Biotech Shareholders Approve Governance and Equity Actions - TipRanks

Apr 02, 2026

PharmaCyte Biotech (PMCB) wins approval for reverse split range and 2M new plan shares - Stock Titan

Apr 02, 2026

Mar 27, 2026

PMCB Stock Chart | PHARMACYTE BIOTECH INC (NASDAQ:PMCB) - ChartMill

Mar 27, 2026

Mar 20, 2026

Insider Sell: How liquid is PharmaCyte Biotech Inc stock2026 Setups & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026

PharmaCyte Biotech (PMCB) logs neutral Form 4 as 10% FEMASYS (FEMY) owner - Stock Titan

Mar 18, 2026

PharmaCyte Biotech (FEMY) reports 7.87% stake including warrants - Stock Titan

Mar 18, 2026